Paksoy has advised Sanofi on the sale of a 70% stake in the company operating its pharmaceutical manufacturing facility in Luleburgaz, Turkiye, to Fareva.
The transaction remains subject to regulatory approval.
Fareva is an industrial subcontracting group active in the pharmaceutical, cosmetics, and industrial sectors.
According to Paksoy, under the agreement, Sanofi will retain a 30% minority interest in the company. The Luleburgaz facility is one of Turkiye’s major pharmaceutical manufacturing sites, with significant production and export capacity.
The Paksoy team included Partner Stephanie Beghe Sonmez, Counsel Zeynep Toma, and Associates Selen Toma and Cansin Taner.
Paksoy did not respond to our inquiry on the matter.
